Bacterial translocation across ePTFE vascular graft surfaces.

[1]  D. Etzioni,et al.  Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. , 2009, Journal of vascular surgery.

[2]  B. Trautner,et al.  Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters , 2007, Antimicrobial Agents and Chemotherapy.

[3]  S. Chambers.  Diagnosis and management of staphylococcal infections of vascular grafts and stents , 2005, Internal medicine journal.

[4]  D. Cuthbertson,et al.  Graft Infectivity of Rifampin and Silver-Bonded Polyester Grafts to MRSA Contamination , 2005, Vascular and Endovascular Surgery.

[5]  T. Nishibe,et al.  Relationship Between Fibril Length and Tissue Ingrowth in the Healing of Expanded Polytetrafluoroethylene Grafts , 2004, Surgery Today.

[6]  H. Greisler,et al.  Biomaterials in the development and future of vascular grafts. , 2003, Journal of vascular surgery.

[7]  Bunt Tj.  Vascular graft infections: an update. , 2001 .

[8]  T. Bunt.  Vascular Graft Infections: An Update , 2001, Cardiovascular surgery.

[9]  S. Wilson.  New alternatives in management of the infected vascular prosthesis. , 2001, Surgical infections.

[10]  O. Wenker,et al.  A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. , 1999, The New England journal of medicine.

[11]  I. Raad,et al.  Intravascular-catheter-related infections , 1998, The Lancet.

[12]  W. Moore,et al.  Long-term results following surgical management of aortic graft infection. , 1991, Archives of surgery.

[13]  D. Bandyk,et al.  The microbiology of explanted vascular prostheses. , 1987, Surgery.

[14]  L. Sauvage,et al.  An experimental study of eight current arterial prostheses. , 1986, Journal of vascular surgery.

[15]  C D Campbell,et al.  A Small Arterial substitute: Expanded Microporous Polytetrafluoroethylene. Patency Versus Porosity , 1975, Annals of surgery.